DDW summer issue now out
From the race to the COVID-19 cure to the new manufacturing technologies that could be a game changer for stem cell therapies.
The summer issue of DDW is now available here.
With COVID-19 still a significant feature in the drug discovery landscape, this issue looks at the race to finding a cure - from the quest to creating a core model for solving the pandemic crisis, to an exciting collaboration involving scientists from academia and industry looking to identify potential SARS-CoV-2 main protease inhibitors.
Other stories in this summer include high content screening and how this tool can identify novel antivirals and vaccines. We also take an in-depth look at personalised medicine and how to hone in on the perfect target, while our business focus asks whether new manufacturing technologies might make the promise of stem cell therapies a reality
Immunotherapy: The coming of age of cancer immunotherapy as a treatment paradigm READ MORE
Kinases and Drug Discovery: Protein Kinases as a Validated Drug Target READ MORE
Oxford University and AstraZeneca partner for COVID-19 vaccine candidate READ MORE
Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate READ MORE
Novasep teams up with AstraZeneca to produce COVID-19 vaccine for Europe READ MORE
Avacta collaboration offers update on Affimer therapy for COVID-19 READ MORE
Dexamethasone identified as potential for treatment of COVID-19 ten weeks ago READ MORE
Epidarex announces £100 million UK venture fund to back life science firms READ MORE
Taconic Biosciences to distribute critical COVID-19 mouse model READ MORE
Symbiosis to manufacture COVID-19 vaccine for clinical trials READ MORE